• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌遗传咨询的实际问题:利弊共存。

Practical aspects of genetic counseling in breast cancer: lights and shadows.

机构信息

Institute of Oncology of Southern Switzerland, Bellinzona, Switzerland.

出版信息

Breast. 2013 Aug;22(4):375-82. doi: 10.1016/j.breast.2013.04.006. Epub 2013 May 11.

DOI:10.1016/j.breast.2013.04.006
PMID:23673076
Abstract

In unselected populations, less than 10% of breast cancers are associated with germline mutations in predisposing genes. Breast cancer type 1 and 2 (BRCA1 and BRCA2) susceptibility genes are the most common involved genes and confer a 10-30 times higher risk of developing the disease compared to the general population. A personal or family history suggestive of inherited breast cancer syndrome may be further evaluated to assess the risk of genetic predisposition and the presence of a genetic mutation. Breast cancer genetic counseling should include a careful risk assessment with associated psychosocial evaluation and support, possible molecular testing, personalized discussion of results. Knowledge of BRCA status can influence individualized cancer risk-reduction strategies. i.e. active surveillance, prophylactic surgery and/or pharmacoprevention.

摘要

在未选择的人群中,不到 10%的乳腺癌与易感基因的种系突变有关。乳腺癌 1 型和 2 型(BRCA1 和 BRCA2)易感基因是最常见的相关基因,与普通人群相比,患该病的风险高出 10-30 倍。具有遗传性乳腺癌综合征提示的个人或家族史可能需要进一步评估,以评估遗传易感性的风险和基因突变的存在。乳腺癌遗传咨询应包括仔细的风险评估,以及相关的社会心理评估和支持、可能的分子检测、结果的个性化讨论。BRCA 状态的知识可以影响个体化癌症风险降低策略,例如主动监测、预防性手术和/或药物预防。

相似文献

1
Practical aspects of genetic counseling in breast cancer: lights and shadows.乳腺癌遗传咨询的实际问题:利弊共存。
Breast. 2013 Aug;22(4):375-82. doi: 10.1016/j.breast.2013.04.006. Epub 2013 May 11.
2
Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.遗传性乳腺癌:2015年风险评估与基因检测最新进展
Am J Obstet Gynecol. 2015 Aug;213(2):161-5. doi: 10.1016/j.ajog.2015.03.003. Epub 2015 Mar 3.
3
Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.遗传性乳腺癌和卵巢癌(HBOC):BRCA1 和 BRCA2、林奇综合征、考登综合征和李-佛美尼综合征的临床特征和咨询。
Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003.
4
Hereditary breast cancer and genetic counseling in young women.年轻女性的遗传性乳腺癌与遗传咨询
Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:7-9. doi: 10.1007/s10549-010-1050-5. Epub 2010 Aug 14.
5
Current and future role of genetic screening in gynecologic malignancies.基因筛查在妇科恶性肿瘤中的当前及未来作用
Am J Obstet Gynecol. 2017 Nov;217(5):512-521. doi: 10.1016/j.ajog.2017.04.011. Epub 2017 Apr 12.
6
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.乳腺癌高危家族中BRCA1、BRCA2、CHEK2和TP53的突变谱。
JAMA. 2006 Mar 22;295(12):1379-88. doi: 10.1001/jama.295.12.1379.
7
Breast and ovarian cancer genetics and prevention.乳腺癌和卵巢癌遗传学与预防
W V Med J. 2003 Sep-Oct;99(5):187-91.
8
Translational advances regarding hereditary breast cancer syndromes.遗传性乳腺癌综合征的转化研究进展。
J Surg Oncol. 2012 Apr 1;105(5):444-51. doi: 10.1002/jso.21856.
9
Genetic testing by cancer site: breast.按癌症部位进行的基因检测:乳房。
Cancer J. 2012 Jul-Aug;18(4):310-9. doi: 10.1097/PPO.0b013e318260946f.
10
Genetic testing for cancer predisposition.癌症易感性的基因检测。
Annu Rev Med. 2001;52:371-400. doi: 10.1146/annurev.med.52.1.371.

引用本文的文献

1
PARP Inhibition and Beyond in BRCA-Associated Breast Cancer in Women: A State-Of-The-Art Summary of Preclinical Research on Risk Reduction and Clinical Benefits.BRCA 相关乳腺癌中聚腺苷二磷酸核糖聚合酶抑制剂的应用及其他进展:风险降低和临床获益的临床前研究的最新综述。
Med Princ Pract. 2022;31(4):303-312. doi: 10.1159/000525281. Epub 2022 May 30.
2
Genetic Literacy and Communication of Genetic Information in Families Concerned with Hereditary Breast and Ovarian Cancer: A Cross-Study Comparison in Two Countries and within a Timeframe of More Than 10 Years.遗传性乳腺癌和卵巢癌相关家庭中的基因知识素养与基因信息交流:两个国家超过10年时间框架内的跨研究比较
Cancers (Basel). 2021 Dec 13;13(24):6254. doi: 10.3390/cancers13246254.
3
Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients.
卵巢癌患者家族史、突变位置与 BRCA1 或 2 突变发生率的相关性。
Cancer Med. 2019 Apr;8(4):1875-1881. doi: 10.1002/cam4.2000. Epub 2019 Mar 1.
4
Evaluation of psychosocial aspects in participants of cancer genetic counseling.癌症遗传咨询参与者的社会心理方面评估。
Hered Cancer Clin Pract. 2017 Sep 20;15:13. doi: 10.1186/s13053-017-0073-x. eCollection 2017.
5
Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.瑞士遗传性乳腺癌/卵巢癌和林奇综合征的癌症易感性级联筛查:研究方案
JMIR Res Protoc. 2017 Sep 20;6(9):e184. doi: 10.2196/resprot.8138.
6
Referral to cancer genetic counseling: do migrant status and patients' educational background matter?转诊至癌症遗传咨询:移民身份和患者的教育背景有影响吗?
J Community Genet. 2017 Oct;8(4):303-310. doi: 10.1007/s12687-017-0326-4. Epub 2017 Sep 4.
7
Women with Family History of Breast Cancer: How Much Are They Aware of Their Risk?有乳腺癌家族史的女性:她们对自身风险了解多少?
J Cancer Educ. 2018 Aug;33(4):915-921. doi: 10.1007/s13187-017-1226-3.
8
Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.CaGene 5.1与6.0在BRCA1/2突变预测方面的比较:对517个乳腺癌/卵巢癌家庭中150次BRCA1/2基因检测的回顾性研究。
J Hum Genet. 2017 Mar;62(3):379-387. doi: 10.1038/jhg.2016.138. Epub 2016 Dec 8.
9
A Relational Approach to Genetic Counseling for Hereditary Breast and Ovarian Cancer.一种针对遗传性乳腺癌和卵巢癌的遗传咨询关系方法。
J Genet Couns. 2017 Apr;26(2):283-299. doi: 10.1007/s10897-016-0022-2. Epub 2016 Oct 19.
10
Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial.将有遗传性乳腺癌和卵巢癌风险的低收入女性有效转诊至遗传咨询:一项随机延迟干预对照试验。
Am J Public Health. 2016 Oct;106(10):1842-8. doi: 10.2105/AJPH.2016.303312. Epub 2016 Aug 23.